Technology and Data

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

In part 2 of our interview with Julia Vu, PharmD, she delves into the AI space within pharmacy practice while touching on the industry’s role in boosting rural health outcomes.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

Despite a myriad of data and news releases about the growing prominence of AI in pharmacy practice, several knowledge and acceptance gaps persist.

As artificial intelligence becomes commonplace in medical practice, officials are gradually uncovering significant safety risks.

With its capabilities improving rapidly in the health care space, technology and pharmacy experts discuss AI’s future place in pharmacy practice as further developments are released.

An exploration of community pharmacists’ perceptions of e-pharmacy, assessing whether they believe it’s a threat or benefit.

Researchers conduct an exploration of e-prescription challenges and potential across pharmacies in Germany.

Amid increased use of artificial intelligence across pharmacy, researchers assess pharmacists’ propensity to trust the emerging automated technology.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

As the pharmacy industry seemingly transforms in real-time, expert pharmacists and digital health experts explain how DTP models are paving a new path for drug distribution.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; provided much-needed nuance to the evolving nature of DTP pharmacy models in today’s landscape.

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

Jennifer Flynn, CPHRM, joins Drug Topics to discuss the nuances in social media use for pharmacists and the potential risks they can encounter.

Annie Lambert, PharmD, BCSCP, discusses compliance solutions and the common gaps existing in the pharmacy compounding industry today.

Lani Bertrand, RPh, discusses Omnicell’s IV compounding solution and how it’s realizing cost savings for pharmacies across the country.

Study authors explore online purchasing habits for prescription-only and OTC medications.

The NCPDP gathered essential members from the pharmacy community in a roundtable discussion on electronic prior authorizations.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of pharmacy businesses to understand evolving and emerging health care technology.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of automation and its emerging role in pharmacy practices.